- Home
- AEON vs SSKN Comparison
AEON vs SSKN Comparison
Compare AEON & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEON
- SSKN
- Stock Information
- Founded
- AEON N/A
- SSKN 1989
- Country
- AEON United States
- SSKN United States
- Employees
- AEON N/A
- SSKN N/A
- Industry
- AEON Biotechnology: Pharmaceutical Preparations
- SSKN Medical/Dental Instruments
- Sector
- AEON Health Care
- SSKN Health Care
- Exchange
- AEON Nasdaq
- SSKN Nasdaq
- Market Cap
- AEON 8.0M
- SSKN 8.9M
- IPO Year
- AEON N/A
- SSKN 2005
- Fundamental
- Price
- AEON $0.64
- SSKN $1.84
- Analyst Decision
- AEON Strong Buy
- SSKN Strong Buy
- Analyst Count
- AEON 1
- SSKN 1
- Target Price
- AEON $360.00
- SSKN $6.00
- AVG Volume (30 Days)
- AEON 104.9K
- SSKN 44.0K
- Earning Date
- AEON 08-19-2025
- SSKN 08-13-2025
- Dividend Yield
- AEON N/A
- SSKN N/A
- EPS Growth
- AEON N/A
- SSKN N/A
- EPS
- AEON 117.22
- SSKN N/A
- Revenue
- AEON N/A
- SSKN $33,620,000.00
- Revenue This Year
- AEON N/A
- SSKN $3.31
- Revenue Next Year
- AEON N/A
- SSKN $9.67
- P/E Ratio
- AEON $0.01
- SSKN N/A
- Revenue Growth
- AEON N/A
- SSKN 3.30
- 52 Week Low
- AEON $0.38
- SSKN $1.78
- 52 Week High
- AEON $115.57
- SSKN $3.79
- Technical
- Relative Strength Index (RSI)
- AEON 32.28
- SSKN 34.47
- Support Level
- AEON $0.70
- SSKN $1.89
- Resistance Level
- AEON $0.75
- SSKN $1.97
- Average True Range (ATR)
- AEON 0.05
- SSKN 0.10
- MACD
- AEON -0.01
- SSKN -0.00
- Stochastic Oscillator
- AEON 1.33
- SSKN 16.82
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.